SLOWAVE THERAPEUTICS LTD
WORPLESDON CHASE, WORPLESDON ROAD, GUILDFORD GU3 3LA- Active
- Private Limited Company
- Company No. 12516408
- Last Updated: 01 Mar 2024
Company Profile
SLOWAVE THERAPEUTICS LTD was incorporated on Friday, March 13, 2020 as a Private Limited Company with registered address in GUILDFORD. SLOWAVE THERAPEUTICS LTD has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 4 years 11 months and 12 days.
| Name | SLOWAVE THERAPEUTICS LTD |
|---|---|
| Company number | 12516408 |
| Company type | Private Limited Company |
| Incorporation date | 13 Mar 2020 |
| Status | Active |
| Industry (SIC 2007) |
Address
| Registered Address |
WORPLESDON CHASE WORPLESDON ROAD GUILDFORD GU3 3LA |
|---|---|
| Country Of Origin | ENGLAND |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
| Name | Nature of Control |
|---|---|
| Dr Andrew Faller Nationality: British |
Dates: Thursday, March 4, 2021 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
| Dr Keith Allan Wafford Nationality: British |
Dates: Thursday, March 4, 2021 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
| Dr Andrew Caerwyn Williams Nationality: British |
Dates: Thursday, March 4, 2021 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Accounts and Confirmation
| Type of accounts | TOTAL EXEMPTION FULL |
|---|---|
| End of financial Year | 31 March |
| Next annual accounts due | 31 December 2024, (-56 days left) |
| Latest accounts | 31 March 2023 |
| Next confirmation statement due | 10 April 2021 |
| Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against SLOWAVE THERAPEUTICS LTD.
Previous Names
| Name | Change Date |
|---|---|
| SLOWAVE THERAPEUTICS LTD | 13 Mar 2020 |